SMYD3 and cancer: A key mechanism underlying the pro-meiotic effect of SMYD3 inhibition is the significant upregulation of CDC25A, a phosphatase recently shown in cancer cell models to be negatively regulated by SMYD3 through post-translational mechanisms (Jiang et al., 2019).